In agreement with our observations, no staining for γ-H2AX was observed in lymphoma cells or colon cancer cells after treatment with oxaliplatin, whereas cisplatin treatment resulted in γ-H2AX foci [39,40]. Here, H2AX is linked to lymphoma.